H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Census population 474,069. North Carolina Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Raleigh clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Raleigh storefront.
Extracellular Matrix (ECM) Therapy in Raleigh, NC for clinics & physicians. ECM therapy products provide n… Compliance support & pricing — contact Hawk Medical.
9.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Population 474,069. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JM documentation are ready before the first application of extracellular matrix therapy.
National Extracellular Matrix (ECM) Therapy notes (how the product actually works)9.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 250k–500k with 474,069 residents will still mix those payers. CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Adult arthritis here is 19.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Raleigh.
CDC PLACES (2023, crude prevalence) estimates 9.1% of adults — 2.9 points below the U.S. 12% figure. Obesity is 30.9%; arthritis is 19.8%. That is place-level BRFSS modeling, not a clinic census and not a Raleigh trial.
City-proper counts are unambiguous and match the URL slug. MSA figures change with OMB delineations and would be easy to get wrong. We would rather under-claim than invent a metro number.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including North Carolina.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 9.1% of adults in Raleigh have diagnosed diabetes — 2.9 points below the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Raleigh, NC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Raleigh is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Raleigh — 2.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
North Carolina Part B wound biologics follow this contractor (siblings: SC, VA, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Raleigh. Useful for joint-program math; still needs a diagnosis and privileging.
No Raleigh storefront. Joe Bradley is an active practice owner. extracellular matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.